Retinal Degeneration Fund

Retinal Degeneration Fund is a Raleigh-based 501(c)(3) venture arm of the Foundation Fighting Blindness that makes mission-related investments in retinal disease therapeutics. It focuses on inherited retinal diseases and dry age-related macular degeneration, backing biotechnology, life sciences, and pharmaceutical companies nearing clinical testing. The fund has a global mandate, with observed investments in the United States and United Kingdom, and participates across seed, early-stage, and later-stage venture rounds. Initial investments typically range from $2 million to $5 million.